Strengthening Our Commitment to Clinical Research Excellence
We’re excited to announce that EvidentIQ Germany is now a proud member of the German Federal Association of Contract Research Organizations (BVMA). This marks an important milestone for us as we continue to grow our presence in the clinical research space and deepen our commitment to quality, collaboration, and innovation.
Why BVMA?
The BVMA represents the leading contract research organizations in Germany and plays a key role in advancing the standards and reputation of clinical research on both a national and international level. By joining the BVMA, EvidentIQ aligns itself with organizations that share our mission: to improve the efficiency and quality of clinical trials through technology and expertise.
What This Means for EvidentIQ
Being part of the BVMA offers us valuable opportunities to:
- Collaborate closely with other CROs, biotech and pharma companies
- Stay ahead of regulatory changes and industry trends
- Contribute actively to shaping the future of clinical research through working groups and expert exchanges
It’s more than just a membership – it’s a step toward stronger partnerships and shared progress.
Powering Clinical Trials with Marvin EDC
Our platform, Marvin EDC, is already supporting a wide range of complex, multicenter clinical trials across the globe. As a CDISC-certified solution, Marvin helps research teams collect, manage, and analyze clinical data efficiently and in compliance with international standards.
With this new partnership, we’re looking forward to extending our impact and helping even more teams accelerate their research.
Looking Ahead
We’re proud to be part of the BVMA community and are excited about the possibilities that lie ahead. Together, we can make a meaningful contribution to the evolution of clinical research and the digital transformation of life sciences.
